Rime Secures $500 Million in Latest Series D Funding Round

Rime secured $500 million in its latest Series D, adding another data point to the Healthcare & Life Sciences funding market.

Rime Raises $500 million in Funding

Rime raised $24M Series A led by M13 Ventures. The work will span employee tools, customer service systems, and sector-specific products used across DXC's global business.

Investors Behind the Funding

The round was backed by M13 Ventures. Capvizr tracks this investor activity alongside sector momentum, co-investor patterns, and recent comparable raises.

Company Profile and Market Context

Rime operates in Healthcare & Life Sciences. Rime's financing adds to recent private-market activity.

Strategic Use of Funds

Triple its local team over the next year after entering the market.

Looking Ahead

The design patterns that will define the speech-to-speech era of AI haven't been built yet,

Source reference: original announcement/article.